Ginkgo Bioworks Holdings (DNA) Interest & Investment Income (2020 - 2026)
Ginkgo Bioworks Holdings' (DNA) quarterly Interest & Investment Income came in at -$78000.0 in Q1 2026, down 172.9% YoY from $107000.0 in Q1 2025, and down 100.35% on a QoQ basis from $22.3 million in Q4 2025.
Analysis
Ginkgo Bioworks Holdings (DNA) Interest & Investment Income (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has 5 years of Interest & Investment Income data on file, last reported at -$78000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 172.9% year-over-year to -$78000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.6 million (down 42.32% YoY) and the FY2025 annual result came in at $22.6 million, down 41.43% from the prior year.
- Interest & Investment Income declined to -$78000.0 in Q1 2026, from $22.3 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $38.6 million in Q4 2024 to a low of -$78000.0 in Q1 2026.
- A 3-year average of $12.2 million and a median of $316000.0 in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2025 — Interest & Investment Income slumped 42.31% — and 2026, when it sank 172.9%.
- Tracing DNA's Interest & Investment Income over 3 years: stood at $38.6 million in 2024, then sank by 42.31% to $22.3 million in 2025, then slumped by 100.35% to -$78000.0 in 2026.
- The last three Interest & Investment Income figures came in at -$78000.0 (Q1 2026), $22.3 million (Q4 2025), and $316000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.21 Bn | 132.36 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.73 Bn | 58.55 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.59 Bn | 52.46 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.13 Bn | 35.04 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.55 Bn | 32.24 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.60 Bn | 27.77 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.70 Bn | 26.54 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Ginkgo Bioworks Holdings | 430.31 Mn | 345.78 Mn | 18.44 Mn | -210,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -210,000.00 |
| Mar 31, 2026 | -78,000.00 |
| Dec 31, 2025 | 22.28 Mn |
| Sep 30, 2025 | 316,000.00 |
| Jun 30, 2025 | -83,000.00 |
| Mar 31, 2025 | 107,000.00 |
| Dec 31, 2024 | 38.61 Mn |
| Dec 31, 2021 | 496,000.00 |
| Sep 30, 2021 | 121,000.00 |
| Dec 31, 2020 | -2.98 Mn |
| Sep 30, 2020 | 3.32 Mn |